Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Fungi in the lungs of people with non-small cell lung cancer

Studies lung fungi and how they relate to non-small cell lung cancer.

Key facts

Who runs it
958th Army Hospital of the Chinese People's Liberation Army
Where
Chongqing, ChinaSee the site
Trial code
Registry title
Study on the Microbial Environment of Non-small Cell Lung Cancer Based on Mycogenomics and Its Clinical Relevance
Status
Recruiting
People taking part
10 people, planned
Started
1 Aug 2026
Expected to end
1 Aug 2028
Type of study
Observational, 2 groups
Record updated
25 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 30 to 80 with non-small cell lung cancer who have not yet had cancer treatment before surgery.

Age
30 to 80 years
Sex
All sexes can join.
Disease stage
Non-small cell lung cancer confirmed by biopsy before surgery, frozen pathology during surgery, or paraffin section after surgery.
Earlier treatment
No chemotherapy, radiotherapy, targeted therapy or immunotherapy before surgery.

Main reasons for not taking part

  • Another primary cancer of a different body system, or lung cancer that has come back
  • Immunodeficiency disease
  • Acute flare of COPD, asthma, bronchiectasis with infection, tuberculosis or pneumoconiosis
  • Recent use of antifungal drugs
  • Basic clinical information (pathological type, clinical stage, treatment plan) cannot be obtained

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Non-small cell lung cancer was diagnosed by biopsy before operation, frozen pathology during operation or paraffin section after operation; The patients were 30 to 80 years old; No chemotherapy, radiotherapy, targeted therapy or immunotherapy were given before operation

Who cannot take part

  • Patients who do not meet the inclusion criteria; Combined with primary malignant tumor of other systems or recurrence of lung cancer, combined with immunodeficiency disease; Acute exacerbation of chronic obstructive pulmonary disease, bronchial asthma, bronchiectasis with infection, tuberculosis and pneumoconiosis; recent use of antifungal drugs; Basic clinical information (such as pathological type, clinical stage and treatment plan) cannot be obtained

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 30 and 80 years old?

Where in China

  • 958th Army HospitalChongqing, ChinaContact: shunhong wang project leaderTaking people

About the trial

What the trial wants to find out

This study aims to uncover the characteristics of the fungal flora in non-small cell lung cancer, and to investigate the relationship between pulmonary fungi and the various pathological subtypes, stages, clinical features of non-small cell lung cancer, as well as patient prognosis. It seeks to provide new perspectives for a comprehensive understanding of non-small cell lung cancer, as well as new approaches for its early diagnosis and prognosis assessment.

The 2 groups in the trial

  • Lung cancer group

    The samples included in this group were lung cancer tissues.

  • Normal lung tissue group

    The samples included in this group were normal lung tissues.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Study on the Microbial Environment of Non-small Cell Lung Cancer Based on Mycogenomics and Its Clinical Relevance
Plain-language title
Fungi in the lungs of people with non-small cell lung cancerGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 13 November 2026.
Fit questions
Built from NCT07783971, who can take part
Record updated
25 August 2026